{"schemaVersion":"1.0","generatedFrom":"https://brightaifuture.com/discoveries/abaucin","record":{"id":"abaucin","headline":"A new lead against resistant bacteria.","canonicalUrl":"https://brightaifuture.com/discoveries/abaucin","datePublished":"2026-09-05","dateModified":null,"sourcePublicationDate":"2023-05-25","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":["biology"],"summary":"Scientists identified abaucin, a compound active against Acinetobacter baumannii, with help from deep learning.","evidenceState":"Experimental","keyFacts":[{"label":"AI’s role","value":"A model prioritized compounds for laboratory testing."},{"label":"Documented result","value":"Abaucin showed activity in experiments, including a mouse wound infection model."},{"label":"Important limitation","value":"Preclinical evidence. Human safety and efficacy are not established."}],"limitations":["Preclinical evidence. Human safety and efficacy are not established."],"evidenceLinks":[{"title":"Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii · Nature Chemical Biology","url":"https://www.nature.com/articles/s41589-023-01349-8","type":"paper"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/abaucin","embedUrl":"https://brightaifuture.com/embed/story/abaucin","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},"claim":{"humanProblem":"Antibiotic resistance narrows the options for treating infections.","priorConstraint":"Screening compounds experimentally is resource intensive.","aiRole":"A model prioritized compounds for laboratory testing.","documentedResult":"Abaucin showed activity in experiments, including a mouse wound infection model.","whyItMayMatter":"A possible starting point for developing a narrow-spectrum antibiotic.","unresolvedQuestions":["Investigate mechanism, optimize the compound, and assess safety before clinical translation."]},"evidenceAssessment":{"state":"Experimental","claimConfidence":"unassessed","reviewState":"source-checked","reviewMethod":null,"reviewNote":"Legacy source check; no named human reviewer is recorded in this projection.","lastSourceReview":"2026-09-05","independentVerification":"not-established-by-this-source-review"},"sources":[{"id":"source:abaucin","title":"Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii · Nature Chemical Biology","url":"https://www.nature.com/articles/s41589-023-01349-8","type":"paper"}],"revisions":[],"corrections":[]}